Express Pharma

Merck relaunches customer collaboration centres with new concept

2

State-of-the-art laboratories will provide full end-to-end process development support and training

Merck, a leading science and technology company, is relaunching its global network of customer collaboration centres, providing customers a shared, exploratory environment with scientists and engineers working to solve their toughest biomanufacturing challenges and helping accelerate development of new therapies.

Formerly known as biomanufacturing science training centres, the new state-of-the-art M Lab collaboration centres provide a simulated manufacturing environment for experiments, troubleshooting and problem solving, in a non-GMP setting, that fosters education and full end-to-end process development support. Customers participate in product demonstrations, hands-on training and proof-of-concept work, as well as apply best practices and new approaches to develop, optimise and scale-up processes and simplify global technology transfer.

“These centres have been an important resource for our customers and the biopharma industry for more than two decades,” said Udit Batra, Member of the Merck Executive Board and CEO, Life Science. “Now reimagined and re-engineered as M Lab Collaboration Centres, we have taken our industry-leading concept to the next level. We are creating unique and inspiring settings where customers can explore new ways to increase productivity and improve processes in close collaboration with our team of experts.”

Merck recently unveiled its first re-modelled centre recently in Tokyo. The network, established in 1995, will also include locations in Brazil, China, France, India, Singapore, South Korea and the US with formal relaunch of centres around the world taking place throughout 2016 and 2017.

Each M Lab Collaboration Centre will welcome customers and collaboration partners from government, academia, regulatory bodies and industry associations, offering application best practices and knowledge sharing tailored to address the specific needs of the local pharmaceutical manufacturers. Customers will have access to sizing and simulation tools and methodologies as well as analytical and modelling support and customer education programmes.

EP News BureauMumbai

Comments are closed.